Experimental Weight Loss Drug Beat Ozempic and Wegovy in Early Trial
People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the average weight loss seen with semaglutide.
Source | RSS or Atom Feed |
Feed Location | http://gizmodo.com/rss |
Feed Title | Gizmodo |
Feed Link | https://gizmodo.com/ |
Reply | 0 comments |